Find clinical trials for Prostate Cancer in Columbus, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Columbus, OH, USA:
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Gahanna, Ohio, United States and 107 other locations
The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to su...
Phase 1
Columbus, Ohio, United States and 3 other locations
Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...
Phase 1
Columbus, Ohio, United States and 17 other locations
To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).
Phase 1
Columbus, Ohio, United States and 20 other locations
Researchers are looking for a better way to treat men who have biochemically recurrent hormone-naïve prostate cancer.Hormone-naïve ...
Phase 2
Columbus, Ohio, United States and 4 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Gahanna, Ohio, United States and 28 other locations
This phase II trial compares the effect of relugolix to leuprolide on cardiac function and performance in patients with prostate cancer...
Phase 2
Columbus, Ohio, United States
Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...
Phase 3
Gahanna, Ohio, United States and 51 other locations
cemiplimab, or in combination with REGN5678. REGN4336, cemiplimab and REGN5678 are a type of treatment for cancer called immunotherapy,and ...
Phase 1, Phase 2
Columbus, Ohio, United States and 10 other locations
to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...
Phase 3
Columbus, Ohio, United States and 322 other locations
Clinical trials
Research sites
Resources
Legal